Rare diseases
Investigational molecules
Locations
331 conditions with trials, the busiest first
872 trials across Europe, recruiting first
Phase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
BulgariaEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
FranceLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BelgiumBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
BulgariaA study to evaluate the effects of zenagamtide on weight and pain in patients with overweight or obesity and knee osteoarthritis
BulgariaA study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis
BulgariaA study comparing dotinurad and allopurinol for lowering uric acid levels in adults with gout and high uric acid in the blood.
PolandStudy of VENT-03 tablets in adults with active cutaneous lupus erythematosus with or without systemic lupus erythematosus
BulgariaStudy on IPN10200 for Treating Cervical Dystonia in Adults
CzechiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BelgiumStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
AustriaStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
BulgariaThe therapies tested most often in Musculoskeletal and connective tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
